Profound Medical Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Profound Medical Corp. on August 14, 2026. The filing discloses significant changes in executive leadership, specifically the resignation of the Chief Financial Officer and the appointment of an interim successor.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and separation terms.
- Interim CFO Base Salary: CAD 300,414.58 annually.
- Interim CFO Bonus Target: 15% of base salary.
- Outgoing CFO Severance: $375,000 cash payment.
- Outgoing CFO Legal Fee Reimbursement: Up to CAD 5,000.
- Outgoing CFO Consulting Rate: CAD 200 per hour.
Material Changes
The primary material change is the departure of Rashed Dewan as Chief Financial Officer, effective August 14, 2026, and the simultaneous appointment of Matthew Sobczyk as Interim Chief Financial Officer.
- Departure: Mr. Dewan resigned and entered into a Mutual Separation Agreement and a Contractor Services Agreement.
- Appointment: Mr. Sobczyk, previously the Corporate Controller since March 2023, was promoted to Interim CFO. He has been with the company since May 2017.
- Transition Services: Mr. Dewan will provide advisory services as an independent contractor from August 17, 2026, through November 25, 2026.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of general business risks. The only contingencies mentioned relate to the terms of the separation and transition agreements, including the vesting of 20,000 restricted share units for the outgoing CFO and the maintenance of his employee benefits for 15 months post-separation.
Investor Verification Checklist
- Verify the total cash outflow impact of the $375,000 severance and ongoing consulting fees.
- Confirm the timeline for the search for a permanent Chief Financial Officer.
- Review the full text of the Separation Agreement and Contractor Services Agreement (to be filed as exhibits to the next Form 10-Q) for additional restrictive covenants or conditions.
- Assess the impact of the leadership transition on the company's financial reporting timeline and internal controls.